33 Dividend Stocks Fit For COVID-19 Times: A September Update

Sep. 07, 2020 1:15 AM ET, , , , , , , , , , , , , , , 3 Comments

Summary

  • Kiplinger listed five sets of dividend stocks qualified to survive the Covid-19 pandemic. Barron's weekly added one more. Those six "our-times" articles include 33 dividend stocks out of 65 listed.
  • Kiplinger article titles were, '15 best Nasdaq stocks'; '20 Best Stocks To Invest In During A Recession'; '11 Best-Stocks to Ride-Out the Coronavirus-Outbreak'; '11 best E-Commerce Stocks'; '10 Health and Pharmaceutical Companies Fighting the COVID-19 Coronavirus.' Barron's posted 'Payout Protection Picks.'
  • The 65 select stocks ranged 0.00% to 6.91% in annual yield and ranged -19.76% to 270.93% in one-year price-target upsides per brokers 9/3/20.
  • Top Ten Fit Stocks For Our-Times boasted net gains from 13.84% to 29.96%.
  • $5k invested in the lowest-priced five of ten top-yield Fit Stocks For Our Times dogs showed 8.84% more net gain than from $5k invested in all ten. Smaller, lower-priced, stocks led the Covid-19 fit times pack again this month.
  • Looking for a portfolio of ideas like this one? Members of The Dividend Dog Catcher get exclusive access to our model portfolio. Get started today »

Foreword

This article is based on five Kiplinger investing articles, plus one from Barron's Weekly, aimed at survival qualities endemic to our Covid-19 locked down recovery times:

Pros' Picks: The 15 Best Nasdaq Stocks, by Dan Burrows, published 5/13/20, "screened the Nasdaq Composite for stocks followed by a minimum of 10 analysts [and]... stocks with an average broker recommendation of Buy or better [to find]...the top-scoring names. The process gave us a host of stocks, from small biotechnology plays to some of the biggest, best-known companies in the world."

20 Best Stocks to Invest In During a Recession, by Will Ashworth, published 2/25/20, "The International Monetary Fund believes the world economy will remain in a weakened state all year, with GDP contracting 3% – before rebounding with 5.8% growth in 2021. The companies best suited to survive, if not thrive, in this kind of environment, are defensive stocks that provide products and services people simply can't live without."

11 Best Stocks to Ride Out the Coronavirus Outbreak, by Charles Lewis Sizemore, CFA, published 4/16/20 "We'll get through this. But in the meantime, we have to deal with a stock market that could suffer considerably at the hands of this worldwide health scare.”

11 Best E-Commerce Stocks for Electrifying Returns, by Patrick Sanders, published 5/5/20, "E-commerce giants have risen to the challenge and largely met consumer expectations," says Jeremie Capron, director of research at New York-based index, advisory, and research company Robo Global. "As a result, we expect an increase in adoption, not only during this crisis but also on the other side of it."

10 Health and Pharmaceutical Companies Fighting the COVID-19 Coronavirus, by Lisa Springer, published 3/12/20 updated 5/18/20, "Here are 10 health and pharmaceutical companies playing a role in the fight to control the COVID-19 coronavirus. Stocks for each of

Get The 'Safer' Dividend Stocks For Our Times

Story

Click here to subscribe to The Dividend Dogcatcher. Get more information and the follow-up to this article.

Catch A Dog On Facebook At 8:45 AM every NYSE trade day on Facebook/Dividend Dog Catcher, A Fredrik Arnold live video highlights a portfolio candidate in the Underdog Daily Dividend Show!

Root for the Underdog. Comment below on any stock ticker to make it eligible for my next FA follower report.

This article was written by

31.22K Followers

Fredrik Arnold is a retired quality service analyst sharing investment ideas with a primary focus on dividend yields by utilizing free cash flow and one-year total returns as trading indicators.

He is the leader of the investing group The Dividend Dog Catcher, where he shares a minimum of one new dividend stock idea per week with focus on yield or extraordinary financial circumstances. All ideas are archived and available after weekly announcement. Learn more.

Analyst’s Disclosure:I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, recommendation or endorsement to buy or sell any security. Prices and returns on equities in this article except as noted are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling same.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Related Stocks

SymbolLast Price% Chg
ABBV--
AbbVie Inc.
DEO--
Diageo plc
EBAY--
eBay Inc.
GILD--
Gilead Sciences, Inc.
GIS--
General Mills, Inc.

Related Analysis